Inhibition of Gαq-regulated signaling in uveal melanoma (Homo sapiens)
From WikiPathways
Description
draft
Quality Tags
Ontology Terms
Bibliography
- Arang N, Lubrano S, Ceribelli M, Rigiracciolo DC, Saddawi-Konefka R, Faraji F, Ramirez SI, Kim D, Tosto FA, Stevenson E, Zhou Y, Wang Z, Bogomolovas J, Molinolo AA, Swaney DL, Krogan NJ, Yang J, Coma S, Pachter JA, Aplin AE, Alessi DR, Thomas CJ, Gutkind JS; ''High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.''; Cell Rep Med, 2023 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
AKT/mTOR | GeneProduct | ||
DAG | Metabolite | CHEBI:18035 (ChEBI) | |
Darovasertib | Metabolite | ||
FAK inhibitor | Metabolite | CHEBI:76617 (ChEBI) | |
FAK | GeneProduct | PTK2 (HGNC) | |
G-beta | GeneProduct | IPR016346 (InterPro) | |
G-gamma | GeneProduct | IPR036284 (InterPro) | |
GNAQ | GeneProduct | GNAQ (HGNC) | |
LATS1 | GeneProduct | LATS1 (HGNC) | |
LATS2 | GeneProduct | LATS2 (HGNC) | |
MAPK1 | GeneProduct | MAPK1 (HGNC) | |
MOB1A | GeneProduct | MOB1A (HGNC) | |
PI3K | GeneProduct | ||
PKC | GeneProduct | ||
PKN1 | GeneProduct | PKN1 (HGNC) | |
PKN2 | GeneProduct | PKN2 (HGNC) | |
PKN3 | GeneProduct | PKN3 (HGNC) | |
PLCB1 | GeneProduct | PLCB1 (HGNC) | |
PLCB2 | GeneProduct | PLCB2 (HGNC) | |
PLCB3 | GeneProduct | PLCB3 (HGNC) | |
PLCB4 | GeneProduct | PLCB4 (HGNC) | |
RHOA | GeneProduct | RHOA (HGNC) | |
ROCK1 | GeneProduct | ROCK1 (HGNC) | |
TEAD1 | GeneProduct | TEAD1 (HGNC) | |
TEAD2 | GeneProduct | TEAD2 (HGNC) | |
TEAD3 | GeneProduct | TEAD3 (HGNC) | |
TEAD4 | GeneProduct | TEAD4 (HGNC) | |
TRIO | GeneProduct | TRIO (HGNC) | |
YAP1 | GeneProduct | YAP1 (HGNC) |
Annotated Interactions
No annotated interactions